Skip to main content
Premium Trial:

Request an Annual Quote

AccessDx Laboratory Teams With Jase Health to Embed Lab Processes Into Electronic Health Records

NEW YORK – AccessDx Laboratory said Monday that it is partnering with data integration firm Jase Health to embed lab processes into clinical workflows within major electronic health records systems.

AccessDx Lab, a Houston-based CAP/CLIA diagnostic lab, offers molecular services including COVID-19 testing, pharmacogenomic testing, cancer genomic screening, and respiratory pathogen panels. Jase Health, of Johnston, Iowa, integrates outside technologies into EHR products from Cerner, Epic Systems, Meditech, Athenahealth, Allscripts Healthcare Solutions, and others.

The firms said that the partnership will help fit personalized medication management, antibiotic stewardship, next-generation sequencing, and other lab services directly into existing clinical workflows.

"Our shared mission of efficiency has enabled our health system partners to rapidly implement and ensure advanced diagnostics solutions are seamlessly available within existing clinical decision support workflows that are positively impacting millions of patient lives," AccessDx Lab CEO Michael Stewart said in a statement. "Clinicians have seen the direct benefit of these solutions through the improved outcomes delivered by these diagnostic solutions, and we look forward to continued success in this partnership."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more